Escriber, Kurt Asher F.
HRN: 23-58-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2023
CEFTRIAXONE 1G (VIAL)
08/28/2023
09/04/2023
IV
350mg
BID
Age W/ Mod. Dehydration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes